quinupristin/dalfopristin will increase the degree or outcome of alfentanil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Slight/Importance Unknown. Our hypotheses target primarily on GlyT1 Procedure in the development of opioid analgesic tolerance. Additionally it is essential to pic